# US 2011/0237815 A1 · Olefin metathesis catalysts and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0237815 A1
- Document ID: US20110237815A1
- Status: Published application
- Kind: A1
- Application number: 13/033,472
- Filed: 2011-02-23
- Published: 2011-09-29
- Earliest claimed: 2006-11-22
- Assignees: Massachusetts Institute of Technology
- Inventors: Adam S. Hock; Richard R. Schrock
- Web page: https://patentgrep.com/patent/US20110237815A1

## CPC

- B01J 31/2295: {Cyclic compounds, e.g. cyclopentadienyls}
- B01J 31/122: {Metal aryl or alkyl compounds}
- B01J 31/1805: {the ligands containing nitrogen}
- B01J 31/181: {Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine}
- B01J 31/2234: {Beta-dicarbonyl ligands, e.g. acetylacetonates}
- B01J 31/2265: {Carbenes or carbynes, i.e.(image)}
- B01J 31/2291: {Olefins}
- C07C 6/04: at a carbon-to-carbon double bond
- B01J 2231/482: asymmetric reactions, e.g. kinetic resolution of racemates
- B01J 2231/54: Metathesis reactions, e.g. olefin metathesis
- B01J 2231/543: alkene metathesis
- B01J 2531/64: Molybdenum
- B01J 2531/66: Tungsten
- C07C 2531/22: Organic complexes
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention provides methods for the synthesis of catalysts and precursors thereof. Methods of the invention may comprise combining a catalyst precursor and at least one ligand to generate a catalytically active species, often under mild conditions and in high yields. In some cases, a wide variety of catalysts may be synthesized from a single catalyst precursor. Methods of the invention may also include the preparation of catalysts which, under reaction conditions known in the art, may have been difficult or impossible to prepare and/or isolate due to, for example, steric crowding at the metal center. The present invention also provides catalyst compositions, and precursors thereof, which may be useful in various chemical reactions including olefin metathesis. In some cases, methods of the invention may reduce the number of synthetic and purification steps required to produce catalysts and/or other reaction products, as well as reducing time, cost, and waste production.

## Claims

### Claim at position 1

1-70. (canceled)

### Claim 71

A compound of formula:
wherein:
M is Mo or W;
R1 is an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl;
R2 and R3 can be the same or different and are hydrogen, or an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl; and
R6 and R7 can be the same or different and are an optionally substituted group selected from heteroalkyl or heteroaryl, or R6 and R7 are joined together to form an optionally substituted bidentate ligand with respect to M; and wherein at least one of R6 and R7 is an oxygen-containing ligand.

### Claim 72 (depends on 71)

The compound according to claim 71, wherein each of R6 and R7 is an oxygen-containing ligand.

### Claim 73 (depends on 71)

The compound according to claim 71, wherein the oxygen-containing ligand coordinates M via an oxygen atom.

### Claim 74 (depends on 73)

The compound according to claim 73, wherein R6 and R7 are joined together to form a biphenolate or binaptholate ligand.

### Claim 75 (depends on 73)

The compound according to claim 73, wherein R1 is substituted aryl.

### Claim 76 (depends on 73)

The compound according to claim 73, wherein R1 is a monosubstituted aryl, 2,6-disubstituted aryl, or 2,4,6-trisubstituted aryl.

### Claim 77 (depends on 73)

The compound according to claim 73, wherein R1 is optionally substituted alkyl.

### Claim 78 (depends on 77)

The compound according to claim 77, wherein R1 is optionally substituted adamantyl.

### Claim 79 (depends on 73)

The compound according to claim 73, wherein one of R2 and R3 is hydrogen and the other of R2 and R3 is an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl.

### Claim 80 (depends on 73)

The compound according to claim 73, wherein:
M is Mo;
R1 is substituted aryl;
R2 is optionally substituted alkyl; and
R3 is hydrogen.

### Claim 81 (depends on 73)

The compound according to claim 73, wherein:
M is W;
R1 is substituted aryl;
R2 is optionally substituted alkyl; and
R3 is hydrogen.

### Claim 82 (depends on 73)

The compound according to claim 73, wherein the oxygen-containing ligand is chiral.

### Claim 83 (depends on 73)

The compound according to claim 73, wherein R6 and R7 are taken together to form an optionally substituted bidentate ligand with M wherein the bidentate ligand is chiral.

### Claim 84 (depends on 73)

The compound according to claim 73, wherein the compound is selected from:
or Mo(N-2,6-Br2-4-MeC6H2)(CHCMe3)[rac-Biphen], wherein Biphen is 3,3′-di-t-butyl-5,5′,6,6′-tetramethyl-1,1′-biphenyl-2,2′-diolate.

### Claim 85 (depends on 71)

A method for preparing the compound according to claim 71, comprising providing a compound of formula:
wherein:
M is Mo or W;
R1 is an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl;
R2 and R3 can be the same or different and are hydrogen, or an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl;
R4 and R5 can be the same or different and are an optionally substituted group selected from heteroalkyl or heteroaryl, or R4 and R5 are joined together to form an optionally substituted bidentate ligand with respect to M; and wherein R4 and R5 each comprise at least one nitrogen atom; and
reacting the compound with an oxygen-containing ligand such that the oxygen-containing ligand replaces at least one of R4 and R5 to form the compound according to claim 71 comprising R6 and R7.

### Claim 86 (depends on 85)

The method according to claim 85, wherein the oxygen-containing ligand replaces both of R4 and R5.

### Claim 87 (depends on 86)

The method according to claim 86, wherein the oxygen-containing ligand coordinates M via an oxygen atom.

### Claim 88 (depends on 87)

The method according to claim 87, wherein R6 and R7 are joined together to form a biphenolate or binaptholate ligand.

### Claim 89 (depends on 87)

The method according to claim 87, wherein the oxygen-containing ligand is chiral.

### Claim 90 (depends on 87)

The method according to claim 87, wherein R6 and R7 are taken together to form an optionally substituted bidentate ligand with M wherein the bidentate ligand is chiral.
